ADVOCATE. CONNECT. INNOVATE.

CLSA Wire

CLSA Board of Directors Engages Lawmakers in Washington, D.C.

May 18, 2019
By Molly Fishman

On Wednesday, May 8, 15 members of CLSA’s Board of Directors spent a full day on Capitol Hill meeting with nearly 20 key legislators and senior staff, on issues of importance to California’s biomedical innovation ecosystem.

Meetings with staff and legislators included: House Majority Leader Kevin McCarthy (R-Bakersfield), House Energy and Commerce Health Subcommittee Chairwoman Anna Eshoo (D-Silicon Valley), House Ways and Means Health Subcommittee Ranking Member Devin Nunes (R-Tulare), Reps. Pete Aguilar (D-San Bernardino), Gil Cisneros (D-Los Angeles), Lou Correa (D-Santa Ana), Jimmy Gomez (D-Los Angeles), Josh Harder (D-Modesto), Ro Khanna (D-Sunnyvale/Silicon Valley), Jerry McNerney (D-Stockton), Katie Porter (D-Irvine), Raul Ruiz, M.D. (D-Palm Desert), Adam Schiff (D-West Hollywood), and Jackie Speier (D-San Mateo/South San Francisco Counties). In addition, CLSA convened a roundtable discussion with members of the New Democrat Coalition, cohosted by Reps. Tony Cárdenas (D-San Fernando Valley) and Scott Peters (D-San Diego).

CLSA’s Board Members discussed issues of importance to the life sciences sector including: how to protect patients from unaffordable out-of-pocket costs and support increased access to prescribed medicines; the need to repeal the medical device excise tax and ensure coverage and payment of breakthrough medical devices; and the urgency to protect the research and innovation ecosystem from threats to intellectual property (including, but not limited to, proposals to assert “march-in” rights under the Bayh-Dole Act and allow for compulsory licensing).

Click here to view photos. Questions? Please contact Molly Fishman, CLSA’s Director of Federal Government Relations (mfishman@califesciences.org).